Cellectis
CLLS
81 hedge funds and large institutions have $325M invested in Cellectis in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 23 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 20
14% more call options, than puts
Call options by funds: $2.38M | Put options by funds: $2.09M
2% more capital invested
Capital invested by funds: $319M → $325M (+$6.02M)
0.58% more ownership
Funds ownership: 26.78% → 27.35% (+0.58%)
6% less funds holding
Funds holding: 86 → 81 (-5)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$17.2M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$5.49M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$4.3M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.16M |
| 5 |
Morgan Stanley
New York
|
+$2.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Nexthera Capital
New York
|
-$15.5M |
| 2 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$3.36M |
| 3 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$3.1M |
| 4 |
PP
Prudential plc
London, England,
United Kingdom
|
-$2.69M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$1.88M |
CLLS Hedge Fund Activity: Q3 2018 in Review
81 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q3 2018, worth a combined $325M — up 1.9% from $319M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of CLLS and 18 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 24 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $17.2M. The largest seller was Nexthera Capital, exiting entirely with an estimated $15.5M sold.
- 81 institutional investors held Cellectis (CLLS) as of Q3 2018, down from 86 in Q2 2018.
- Funds reported $325M of Cellectis stock for Q3 2018, up 1.9% quarter-over-quarter.
- 18 funds opened new Cellectis positions in Q3 2018 and 23 closed out, a net change of -5 holders.
- The largest Cellectis buyer in Q3 2018 was Armistice Capital, an estimated $17.2M added.
- The largest Cellectis seller in Q3 2018 was Nexthera Capital, an estimated $15.5M sold.
Based on aggregated 13F filings for Q3 2018.